To connoisseurs of fine cinematic car chases, there's nothing better than seeing a hot rod roaring down the street in reverse to escape certain doom. What's better? Doing it yourself, but let's be ...

The Election Commission of India has initiated the Special Intensive Revision for the 2025 electoral rolls, ensuring accurate voter information. Citizens can verify their details, make corrections, ...

Tilray Brands Inc (NASDAQ: TLRY) shares are trading lower in Wednesday’s after-hours session after the company announced a reverse stock split. What To Know: After the market close on Wednesday, ...

Booking (BKNG) may be nearing a key inflection point. After a stretch of consolidation off its record highs, the stock is once again pressing into a price zone that has repeatedly signaled the start ...

Some of the citations that underpin the science in the White House’s sweeping “MAHA Report” appear to have been generated using artificial intelligence, resulting in numerous garbled scientific ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

SALT LAKE CITY - Recursion (NASDAQ:RXRX) will present new clinical data from its ongoing TUPELO Phase 1b/2 trial of REC-4881 in Familial Adenomatous Polyposis (FAP) during a company webinar scheduled ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...